Denosumab: Nonsurgery Option for Giant Cell Tumor of BoneDenosumab: Nonsurgery Option for Giant Cell Tumor of Bone
Safety and efficacy data from a phase 2 study of denosumab have been published, weeks after the US Food and Drug Administration expanded its use to include the treatment of giant cell tumor of bone. Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Cancer & Oncology | Food and Drug Administration (FDA) | Health | Hematology | Study | Xgeva